Veritac Group

Blog

#PrivateEquity #GrowthStage

When Mid-Market Companies Should Refresh Their GTM Strategy

Erika Rosenthal Mar 9, 2026

#PrivateEquity #GrowthStage

Why Companies Stall at $20M Revenue — And How Revenue Operations Can Restart Growth

Erika Rosenthal Mar 6, 2026

#MedTech

Medical Device Growth Engines: The 7 Critical Mistakes Stalling Your Revenue Machine

Erika Rosenthal Mar 5, 2026

#mid-market

The CEO’s Guide to RevOps Transformation for Mid-Market & PE-Backed SaaS Companies

David Garcia Dec 10, 2025

#PrivateEquity #GrowthStage

The High Price of Not Knowing Your Customer

Beth VanStory Dec 10, 2025

#PrivateEquity #RevOps #Consultants #GrowthExperts

Is Your Healthcare Company Go-to-Market Built for Tomorrow?

John Auer Nov 13, 2025

#healthcareGTM

Scaling Healthcare Ventures: 8 Lessons in Profitable Growth

Erika Rosenthal Nov 12, 2025

#PrivateEquity #GrowthStage

Is Your Go-to-Market Built for Today or Tomorrow?

John Auer Oct 21, 2025

#PrivateEquity #RevOps #Consultants #GrowthExperts

Under the Surface: How GTM Mastery Drives Exit Multiples in the Mid-Market

John Auer Sep 8, 2025

#PrivateEquity #RevOps #Consultants #GrowthExperts

PE’s 100-Day Playbook to Optimize GTM at Mid-Market B2B Acquisitions

John Auer Sep 8, 2025